|
業務類別
|
-- |
|
業務概覽
|
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC. |
| 公司地址
| 185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN |
| 電話號碼
| +86 4009222099 |
| 傳真號碼
| +86 2258213677 |
| 公司網頁
| https://www.cansinotech.com |
| 員工數量
| 1105 |
| Dr. Yu Xuefeng |
Chairman of the Board, Chief Executive Officer and General Manager |
-- |
16/04/2025 |
| Dr. Bai Chao Shou |
Director, Chief Operating Officer and Deputy General Manager |
-- |
16/04/2025 |
| Ms. Jing Wang |
Director, Chief commercial officer and Deputy General Manager |
-- |
16/04/2025 |
|
|
| Mr. Chi Shing Li |
Director |
16/04/2025 |
| Dr. Yu Xuefeng |
Chairman of the Board, Chief Executive Officer and General Manager |
16/04/2025 |
| Dr. Bai Chao Shou |
Director, Chief Operating Officer and Deputy General Manager |
16/04/2025 |
| Mr. Shuifa Gui |
Independent Director |
16/04/2025 |
| Mr. Liu Jianzhong |
Independent Director |
16/04/2025 |
| Mr. Yiu Leung Andy Cheung |
Independent Director |
16/04/2025 |
| Ms. Jing Wang |
Director, Chief commercial officer and Deputy General Manager |
16/04/2025 |
|
|
|
|
